BREVITAS
WORD
Not all those who wander are lost. - J.R.R. Tolkein
MONEY & LABORJAMES MCCUSKER, EVERETT HERALD, WA - Most of us tend to think of our financial system in fairly simple terms -- maybe a little more complicated than Jimmy Stewart's Bailey Building & Loan in Bedford Falls, but not much. Actually, though, it is a lot different. To get a perspective on the change, think of a company such as Boeing. It makes airplanes and sells them to airlines around the world. The design, engineering and manufacturing process has become more complex, but managing the whole thing is still something that ordinary mortals can grasp, at least in theory. Maybe it's not so easy that a caveman could do it, but most of us can at least understand what is involved. Now suppose that Boeing's customers, the airlines, were concerned about their risk of not needing the airplane when it is delivered, and so they sell options on it -- first to other airlines and then to anybody who wants to speculate in aircraft futures. Then, Boeing suppliers start taking similar actions so that eventually the ownership and delivery schedule of every sub-assembly and part has been divided, optioned out and sold to individuals and groups around the world.
At that point, the management of Boeing would become very complex. If everything goes according to schedule, of course, there is no problem. But a disruption of any sort could cause a collapse of critical portions of the assembly process.
RADAR - "To live in
BUS TOUR OF REPOS BEING OFFERED BY REALTY FIRM
OUTLYING PRECINCTS
POLITICS 1 Time is reporting that lobbyists and developer Lanny Young -- the man who claimed he gave illegal campaign contributions to former Governor Don Siegelman (D) -- also gave sworn statements to federal prosecutors that also have illegal campaign contributions and gifts to several prominent Alabama Republicans. Young's testimony formed the basis of half of the 32 felony counts the feds filed against Siegelman during his failed 2006 campaign to recapture the Governor's Mansion. According to the magazine, Young testified that other recipients of his illegal contributions included US Senator Jeff Sessions (R) and then-Attorney General Bill Pryor (R), who is now a federal judge. Young's testimony -- now that it has come to light -- seems to lend credence to Siegelman's claim that the Bush Administration selectively prosecuted only him on the charges due to political considerations purportedly advanced at the time behind the scenes by then-White House political advisor Karl Rove. Sessions is facing re-election this year, but is heavily favored over State Senator Vivian Davis Figures (D).
DEUTSCHE WELLE, GERMANY -
PR WATCH For Mark Penn, who recently resigned as Hillary Clinton's chief campaign strategist, the campaign "has been about as effective an economic stimulus program for himself as anything his clients have ever proposed for the nation," reports Mike Madden. Penn's polling firm, Penn, Schoen & Berland Associates, has billed the campaign $14 million for polling, direct mail, and consulting services -- nearly 9 percent of her entire campaign expenditures. "Getting rich off free-spending campaigns is, of course, a time-honored tradition in politics, and it isn't just Mark Penn who does it," Madden adds, noting that campaign consultants to Barack Obama and John Kerry have also raked in millions of dollars. "Campaign finance experts say most people who give to candidates figure it's being spent on TV ads. What few of them know is how much of the 'TV ad' budget winds up paying for a consultant's beach house."
JOSH GOODMAN, GOVERNING A candidate for lieutenant governor in
MARK FINKELSTEIN,NEWS BUSTERS A week ago I was mystified when Chris Matthews went out of his way to butter up Ed Rendell when the Dem Pennsylvania governor appeared on Hardball. . . Now, call it mystery likely solved. According to one account, Matthews has approached Rendell for help in a possible 2010 U.S. Senate run. That seems an ever-more-likely scenario, given Matthews's decidedly non-Shermanesque response to a suggestion that he's well-positioned to make a run against Arlen Specter (R-Pa.) in 2010. The "Hardball" host's intriguing comments came in response to Philly-based radio talk show host Michael Smerconish who speculated on Wednesday's show about the possibility of a Matthews Senate campaign. Unexpectedly, the former Tip O'Neill aide declined to tamp down the rumor. . .
POLITICAL PUNCH, ABC NEWS - At a Michelle Obama event, reporters from the
CBS - As polls continue to show Barack Obama maintaining a double-digit lead over Hillary Clinton in the May 6
COLLEGE
WALL STREET JOURNAL - College students in need of private loans to pay for the coming academic year will have to grapple with higher interest rates and tougher credit checks. Even then, some who have qualified for such loans in the past probably won't this year. . . Private loans have been one of the fastest-growing ways to pay for college. In 2006-07, students and their parents took out an estimated $17.1 billion in private loans, up from $1.57 billion in 1996-1997, according to the most recent tally from the College Board. The $17.1 billion represents 22% of all the borrowing to pay for college that year.
BACKYARD GREENS
ARKANSAS DEMOCRAT GAZETTE Abel Tomlinson began thinking about running for Congress when he realized
HEALTH & SCIENCE
SARAH BOSELEY, GUARDIAN, UK The real benefit of some cancer drugs may be exaggerated because of a growing tendency for firms and investigators to call a premature halt to trials the moment a benefit appears, experts warn today. Italian researchers writing in the cancer journal Annals of Oncology reveal a dramatic increase in the number of studies terminated early. They claim that in some cases drug companies are rushing with early, incomplete results to the licensing authorities. One reason, the researchers suggest, is a desire to get their drugs on the market ahead of their competitors. Among 14 of these early results published between 2005 and 2007, 11 were used to support a licence application. "This suggests a commercial component in stopping trials prematurely. In fact, this strategy could guarantee quicker access to the market for companies," said one of the authors, Dr Giovanni Apolone from the Mario Negri Institute for Pharmacological Research in


1 Comments:
...and not all who are quoted get their names spelled right.
Post a Comment
<< Home